BRIEF published on 06/12/2026 at 09:25, 1 month 29 days ago CS2009: A Potential Game-Changer in Immuno-Oncology Clinical Trials Immuno-oncology ASCO 2026 CS2009 Trispecific Antibody
PRESS RELEASE published on 06/12/2026 at 09:20, 1 month 29 days ago CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody) ASCO 2026 Key Highlights Clinical datasets presented at ASCO 2026 validate trispecific mechanism of CS2009 in immuno-oncology, showing potential for long-term survival benefits and favorable tolerability Immuno-oncology ASCO 2026 CS2009 Trispecific Mechanism Clinical Datasets
BRIEF published on 06/12/2026 at 09:07, 1 month 29 days ago CS2009 at ASCO 2026: Clinical Potential and Safety Profile Immuno-oncology ASCO 2026 CS2009 Trispecific Antibody VEGF Toxicity
PRESS RELEASE published on 06/12/2026 at 09:02, 1 month 29 days ago CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody) ASCO 2026 Key Highlights Clinical datasets presented at ASCO 2026 validate trispecific synergistic mechanism of CS2009 for next-gen immuno-oncology backbone therapy Immuno-oncology ASCO 2026 CS2009 Trispecific Mechanism Clinical Datasets
Published on 08/12/2026 at 00:00, 7 hours 20 minutes ago Organto Foods Reports Record Second Quarter 2026 Financial Results
Published on 08/11/2026 at 23:40, 7 hours 40 minutes ago RJK Explorations Ltd. Announces Private Placement for Gross Proceeds of up to $100,000
Published on 08/11/2026 at 23:15, 8 hours 5 minutes ago Fermi and Hillcore Energy Capital Announce 2.6 Gigawatt Power Strategic Alliance for Project Matador
Published on 08/11/2026 at 23:00, 8 hours 20 minutes ago Prospectiva Resources Ltd. Completes Qualifying Transaction
Published on 08/11/2026 at 22:55, 8 hours 25 minutes ago NV Gold Announces Non-Brokered Private Placement
Published on 08/12/2026 at 07:10, 10 minutes ago Deutsche Konsum Real Estate AG publishes quarterly statement for the first nine months of the 2025/2026 financial year
Published on 08/12/2026 at 07:00, 20 minutes ago MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor
Published on 08/12/2026 at 07:00, 20 minutes ago SCHOTT Pharma with strong third quarter and on track for planned growth
Published on 08/12/2026 at 07:00, 20 minutes ago TUI delivered resilient Q3 underlying EBIT of €234.6m (at CC), demonstrating the strength of its business despite geopolitical headwinds and one-offs, FY26 guidance reaffirmed
Published on 08/12/2026 at 07:00, 20 minutes ago E.ON remains on track and continues to invest in the energy transition
Published on 08/10/2026 at 18:00, 1 day 13 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 11:53, 1 day 19 hours ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 1 day 19 hours ago GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 1 day 21 hours ago Number of shares and voting rights - July 2026 (In French only)
